09:15 AM EST, 11/11/2025 (MT Newswires) -- Health care stocks were mixed pre-bell Tuesday, with the Health Care Select Sector SPDR Fund ( XLV ) up 0.3% and the iShares Biotechnology ETF (IBB) marginally declining.

Soleno Therapeutics ( SLNO ) stock was up more than 8% higher after the company said it has signed an accelerated share repurchase agreement for $100 million of its common shares.

Surmodics ( SRDX ) shares were up nearly 50% after the company said the US District Court for the Northern District of Illinois denied a request by the Federal Trade Commission and certain state regulators for a preliminary injunction that would have blocked its proposed acquisition by a GTCR affiliate.

EnGene ( ENGN ) stock was up more than 40% after the company said additional preliminary data from the pivotal cohort of its mid-stage trial of detalimogene voraplasmid showed an improved complete response rate of 62% in six months for patients with high-risk, Bacillus Calmette-Guerin unresponsive non-muscle invasive bladder cancer patients with carcinoma in situ.